Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management
Status:
Unknown status
Trial end date:
2019-10-25
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess if dextromethorphan administered during 4 weeks induces a
decrease of pain intensity in breast cancer patients suffering from chemotherapy-induced
peripheral neuropathy compared to placebo group.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborators:
Dr Dominique JOLY / Dr Christine VILLATTE Dr Gisèle PICKERING Dr Noémie DELAGE / Dr Fabienne MARCAILLOU / Dr Pascale PICARD Pr Claude DUBRAY